Intérêt actuel des selective progesterone receptor modulators (SPRM) dans l’endométriose
Authors:
- P. MervielPMP. Merviel
- E. LourdelELE. Lourdel
- S. SanguinSSS. Sanguin
- O. GagneurOGO. Gagneur
- R. CabryRCR. Cabry
- A. NasreddineANA. Nasreddine
- 30 September 2013
- journal article
- Published by Elsevier in Gynécologie Obstétrique & Fertilité
- Vol. 41 (9) , 524-528
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Ulipristal Acetate versus Placebo for Fibroid Treatment before SurgeryNew England Journal of Medicine, 2012
- Ulipristal Acetate versus Leuprolide Acetate for Uterine FibroidsNew England Journal of Medicine, 2012
- Proceedings from the National Institute of Child Health and Human Development Conference on the Uterine Fibroid Research Update WorkshopFertility and Sterility, 2011
- The effect of mifepristone on breast cell proliferation in premenopausal women evaluated through fine needle aspiration cytologyHuman Reproduction, 2008
- Coregulators: From Whence Came These “Master Genes”Molecular Endocrinology, 2007
- Prevention of Brca1 -Mediated Mammary Tumorigenesis in Mice by a Progesterone AntagonistScience, 2006
- Progesterone antagonists and progesterone receptor modulators: an overviewSteroids, 2003
- Treatment of EndometriosisNew England Journal of Medicine, 2001
- The evidence for the management of endometriosisCurrent Opinion in Obstetrics and Gynecology, 1998
- Endometriosis—A disease because it is characterized by bleedingAmerican Journal of Obstetrics and Gynecology, 1997